{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:46:23Z","timestamp":1792125983896,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB F6107"],"award-info":[{"award-number":["SFB F6107"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB F6101"],"award-info":[{"award-number":["SFB F6101"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB F6107"],"award-info":[{"award-number":["SFB F6107"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P 34269"],"award-info":[{"award-number":["P 34269"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    CDK6 and STAT5B are well-established oncogenic drivers, but their interplay during transformation remains poorly understood. Here, we demonstrate that simultaneous genetic deletion of\n                    <jats:italic>Cdk6<\/jats:italic>\n                    and\n                    <jats:italic>Stat5b<\/jats:italic>\n                    in an\n                    <jats:italic>NPM-ALK<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>Tg\/+<\/jats:italic>\n                    <\/jats:sup>\n                    mouse model completely prevents tumor formation. Immature DN2\/3 thymocytes are identified as the cellular origin of ALK-driven malignancy. Single-cell transcriptomics reveals a tumor-specific differentiation trajectory that is fully disrupted by combined\n                    <jats:italic>Cdk6\/Stat5b<\/jats:italic>\n                    loss, coinciding with a developmental shift. We uncover shared transcriptional targets of CDK6 and STAT5B involved in cell-cycle regulation and apoptosis at the tumor initiation stage. In human ALCL cells, dual deletion of CDK6 and STAT5B induces context-dependent synthetic lethality, exposing a potential therapeutic vulnerability. A transcriptional signature derived from CDK6\/STAT5B-dependent tumor initiation genes identifies a high-risk subgroup of ALCL patients with worse survival. Together, these findings establish a molecular link between thymocyte development, the crosstalk of CDK6 and STAT5B, oncogenic signaling, and clinical outcome in ALCL.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-77466-4","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:33:50Z","timestamp":1789497230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ablation of CDK6 and STAT5B rewires T cell developmental dynamics and prevents ALK+ lymphoma formation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2470-4868","authenticated-orcid":false,"given":"Jonatan","family":"Kendler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Sexl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5446-9136","authenticated-orcid":false,"given":"Alessia","family":"Schirripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8439-4148","authenticated-orcid":false,"given":"Elisabeth","family":"Gamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5312-6039","authenticated-orcid":false,"given":"Hager","family":"El Kersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Grausenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8383-1330","authenticated-orcid":false,"given":"Klavdija","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6028-4696","authenticated-orcid":false,"given":"Dua","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5739-3966","authenticated-orcid":false,"given":"Giorgia","family":"Damonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-5352","authenticated-orcid":false,"given":"Tania","family":"Brandstoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Prchal-Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-9910","authenticated-orcid":false,"given":"Sabine","family":"Lagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-1338","authenticated-orcid":false,"given":"Lukas","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-9463","authenticated-orcid":false,"given":"Richard","family":"Moriggl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp B.","family":"Staber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Sexl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7937-4245","authenticated-orcid":false,"given":"Karoline","family":"Kollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6666-9773","authenticated-orcid":false,"given":"Thorsten","family":"Klampfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"77466_CR1","doi-asserted-by":"publisher","unstructured":"Lowe, E. J. & Woessmann, W. Anaplastic large cell lymphoma in children and adolescents. Br. J. Haematol.; https:\/\/doi.org\/10.1111\/bjh.20154 (2025).","DOI":"10.1111\/bjh.20154"},{"key":"77466_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2291","volume":"8","author":"R Chiarle","year":"2008","unstructured":"Chiarle, R., Voena, C., Ambrogio, C., Piva, R. & Inghirami, G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat. Rev. Cancer 8, 11\u201323 https:\/\/doi.org\/10.1038\/nrc2291 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"77466_CR3","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","volume":"96","author":"H Stein","year":"2000","unstructured":"Stein, H. et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96, 3681\u20133695 https:\/\/doi.org\/10.1182\/blood.V96.12.3681 (2000).","journal-title":"Blood"},{"key":"77466_CR4","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","volume":"29","author":"L Lamant","year":"2011","unstructured":"Lamant, L. et al. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 29, 4669\u20134676 https:\/\/doi.org\/10.1200\/JCO.2011.36.5411 (2011).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77466_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2141.2009.07754.x","volume":"146","author":"C Damm-Welk","year":"2009","unstructured":"Damm-Welk, C. et al. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation. Br. J. Haematol. 146, 306\u2013309 https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07754.x (2009).","journal-title":"Br. J. Haematol."},{"key":"77466_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","volume":"21","author":"A Zamo","year":"2002","unstructured":"Zamo, A. et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 21, 1038\u20131047 https:\/\/doi.org\/10.1038\/sj.onc.1205152 (2002).","journal-title":"Oncogene"},{"key":"77466_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01640-7","volume":"21","author":"I Garces de Los Fayos Alonso","year":"2022","unstructured":"Garces de Los Fayos Alonso, I. et al. PDGFR\u03b2 promotes oncogenic progression via STAT3\/STAT5 hyperactivation in anaplastic large cell lymphoma. Mol. Cancer 21, 172. https:\/\/doi.org\/10.1186\/s12943-022-01640-7 (2022).","journal-title":"Mol. Cancer"},{"key":"77466_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm1249","volume":"11","author":"R Chiarle","year":"2005","unstructured":"Chiarle, R. et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat. Med. 11, 623\u2013629 https:\/\/doi.org\/10.1038\/nm1249 (2005).","journal-title":"Nat. Med."},{"key":"77466_CR9","first-page":"6517","volume":"61","author":"M Nieborowska-Skorska","year":"2001","unstructured":"Nieborowska-Skorska, M. et al. Role of signal transducer and activator of transcription 5 in nucleophosmin\/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. Cancer Res. 61, 6517\u20136523 (2001).","journal-title":"Cancer Res."},{"key":"77466_CR10","first-page":"3591","volume":"92","author":"L Brugi\u00e8res","year":"1998","unstructured":"Brugi\u00e8res, L. et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92, 3591\u20133598 (1998).","journal-title":"Blood"},{"key":"77466_CR11","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/cncr.21438","volume":"104","author":"A Rosolen","year":"2005","unstructured":"Rosolen, A. et al. Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer 104, 2133\u20132140 https:\/\/doi.org\/10.1002\/cncr.21438 (2005).","journal-title":"Cancer"},{"key":"77466_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1200\/JCO.2005.11.075","volume":"23","author":"JH Laver","year":"2005","unstructured":"Laver, J. H. et al. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 23, 541\u2013547 https:\/\/doi.org\/10.1200\/JCO.2005.11.075 (2005).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77466_CR13","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood.v97.12.3699","volume":"97","author":"K Seidemann","year":"2001","unstructured":"Seidemann, K. et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90. Blood 97, 3699\u20133706 https:\/\/doi.org\/10.1182\/blood.v97.12.3699 (2001).","journal-title":"Blood"},{"key":"77466_CR14","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore, F. et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 30, 3093\u20133099 https:\/\/doi.org\/10.1200\/JCO.2011.40.2719 (2012).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77466_CR15","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.2147\/CMAR.S190098","volume":"11","author":"H Hou","year":"2019","unstructured":"Hou, H. et al. The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis. Cancer Manag. Res. 11, 4109\u20134118 https:\/\/doi.org\/10.2147\/CMAR.S190098 (2019).","journal-title":"Cancer Manag. Res."},{"key":"77466_CR16","doi-asserted-by":"publisher","unstructured":"Noguchi, K. & Ikawa, Y. Strategy for pediatric patients with relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: a review. Cancers 15; https:\/\/doi.org\/10.3390\/cancers15245733 (2023).","DOI":"10.3390\/cancers15245733"},{"key":"77466_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41375-024-02468-4","volume":"39","author":"TI Shaw","year":"2025","unstructured":"Shaw, T. I. et al. Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma. Leukemia 39, 199\u2013210 https:\/\/doi.org\/10.1038\/s41375-024-02468-4 (2025).","journal-title":"Leukemia"},{"key":"77466_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ni.2247","volume":"13","author":"K Narayan","year":"2012","unstructured":"Narayan, K. et al. Intrathymic programming of effector fates in three molecularly distinct \u03b3\u03b4 T cell subtypes. Nat. Immunol. 13, 511\u2013518 https:\/\/doi.org\/10.1038\/ni.2247 (2012).","journal-title":"Nat. Immunol."},{"key":"77466_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ni.2590","volume":"14","author":"M Mingueneau","year":"2013","unstructured":"Mingueneau, M. et al. The transcriptional landscape of \u03b1\u03b2 T cell differentiation. Nat. Immunol. 14, 619\u2013632 https:\/\/doi.org\/10.1038\/ni.2590 (2013).","journal-title":"Nat. Immunol."},{"key":"77466_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L., Su, Y., Jiao, A., Wang, X. & Zhang, B. T cells in health and disease. Signal Transduct. Target. Ther. 8, 235 https:\/\/doi.org\/10.1038\/s41392-023-01471-y (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"77466_CR21","doi-asserted-by":"publisher","unstructured":"Frutos D\u00edaz-Alejo, J. et al. Molecular insights into the diagnosis of anaplastic large cell lymphoma: beyond morphology and immunophenotype. Int. J. Mol. Sci. 26; https:\/\/doi.org\/10.3390\/ijms26125871 (2025).","DOI":"10.3390\/ijms26125871"},{"key":"77466_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-025-00797-9","volume":"25","author":"C Voena","year":"2025","unstructured":"Voena, C., Ambrogio, C., Iannelli, F. & Chiarle, R. ALK in cancer: from function to therapeutic targeting. Nat. Rev. Cancer 25, 359\u2013378 https:\/\/doi.org\/10.1038\/s41568-025-00797-9 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"77466_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1241532","volume":"13","author":"R Wu","year":"2023","unstructured":"Wu, R. & Lim, M. S. Updates in pathobiological aspects of anaplastic large cell lymphoma. Front. Oncol. 13, 1241532 https:\/\/doi.org\/10.3389\/fonc.2023.1241532 (2023).","journal-title":"Front. Oncol."},{"key":"77466_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10087","volume":"7","author":"TIM Malcolm","year":"2016","unstructured":"Malcolm, T. I. M. et al. Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress. Nat. Commun. 7, 10087 https:\/\/doi.org\/10.1038\/ncomms10087 (2016).","journal-title":"Nat. Commun."},{"key":"77466_CR25","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/onc.2014.112","volume":"34","author":"N Moti","year":"2015","unstructured":"Moti, N. et al. Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin. Oncogene 34, 1843\u20131852 https:\/\/doi.org\/10.1038\/onc.2014.112 (2015).","journal-title":"Oncogene"},{"key":"77466_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cancers9100141","volume":"9","author":"S Turner","year":"2017","unstructured":"Turner, S. An exploration into the origins and pathogenesis of anaplastic large cell lymphoma, anaplastic lymphoma kinase (ALK)-positive. Cancers 9, 141 https:\/\/doi.org\/10.3390\/cancers9100141 (2017).","journal-title":"Cancers"},{"key":"77466_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","volume":"126","author":"G Hapgood","year":"2015","unstructured":"Hapgood, G. & Savage, K. J. The biology and management of systemic anaplastic large cell lymphoma. Blood 126, 17\u201325 https:\/\/doi.org\/10.1182\/blood-2014-10-567461 (2015).","journal-title":"Blood"},{"key":"77466_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccr.2013.07.012","volume":"24","author":"K Kollmann","year":"2013","unstructured":"Kollmann, K. et al. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 24, 167\u2013181 https:\/\/doi.org\/10.1016\/j.ccr.2013.07.012 (2013).","journal-title":"Cancer Cell"},{"key":"77466_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1158\/0008-5472.CAN-08-2473","volume":"69","author":"MG Hu","year":"2009","unstructured":"Hu, M. G. et al. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res. 69, 810\u2013818 https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2473 (2009).","journal-title":"Cancer Res."},{"key":"77466_CR30","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.4049\/jimmunol.173.4.2307","volume":"173","author":"J Kang","year":"2004","unstructured":"Kang, J. et al. STAT5 is required for thymopoiesis in a development stage-specific manner. J. Immunology 173, 2307\u20132314 https:\/\/doi.org\/10.4049\/jimmunol.173.4.2307 (2004).","journal-title":"J. Immunology"},{"key":"77466_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1074-7613(00)80052-7","volume":"10","author":"C Pallard","year":"1999","unstructured":"Pallard, C. et al. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 10, 525\u2013535 https:\/\/doi.org\/10.1016\/S1074-7613(00)80052-7 (1999).","journal-title":"Immunity"},{"key":"77466_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ni.3122","volume":"16","author":"A Boudil","year":"2015","unstructured":"Boudil, A. et al. IL-7 coordinates proliferation, differentiation and Tcra recombination during thymocyte \u03b2-selection. Nat. Immunol. 16, 397\u2013405 https:\/\/doi.org\/10.1038\/ni.3122 (2015).","journal-title":"Nat. Immunol."},{"key":"77466_CR33","doi-asserted-by":"publisher","unstructured":"Suske, T. et al. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia. J. Clin. Investig. 134; https:\/\/doi.org\/10.1172\/JCI168536 (2024).","DOI":"10.1172\/JCI168536"},{"key":"77466_CR34","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2002-05-1343","volume":"101","author":"R Chiarle","year":"2003","unstructured":"Chiarle, R. et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919\u20131927 https:\/\/doi.org\/10.1182\/blood-2002-05-1343 (2003).","journal-title":"Blood"},{"key":"77466_CR35","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage, K. J. et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 111, 5496\u20135504 https:\/\/doi.org\/10.1182\/blood-2008-01-134270 (2008).","journal-title":"Blood"},{"key":"77466_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01520-0","volume":"21","author":"L Babin","year":"2022","unstructured":"Babin, L. et al. De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells. Mol. Cancer 21, 65 https:\/\/doi.org\/10.1186\/s12943-022-01520-0 (2022).","journal-title":"Mol. Cancer"},{"key":"77466_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/299065a0","volume":"299","author":"U Schwab","year":"1982","unstructured":"Schwab, U. et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin\u2019s disease and a subset of normal lymphoid cells. Nature 299, 65\u201367 https:\/\/doi.org\/10.1038\/299065a0 (1982).","journal-title":"Nature"},{"key":"77466_CR38","unstructured":"Murine Thymocytes - Single Cell Portal. Available at https:\/\/singlecell.broadinstitute.org\/single_cell\/study\/SCP1833\/murine-thymocytes (2025)."},{"key":"77466_CR39","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1073\/pnas.0507350103","volume":"103","author":"Z Yao","year":"2006","unstructured":"Yao, Z. et al. Stat5a\/b are essential for normal lymphoid development and differentiation. Proc. Natl. Acad. Sci. USA 103, 1000\u20131005 https:\/\/doi.org\/10.1073\/pnas.0507350103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77466_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.smim.2012.02.002","volume":"24","author":"C Hong","year":"2012","unstructured":"Hong, C., Luckey, M. A. & Park, J.-H. Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. Semin. Immunol. 24, 151\u2013158 https:\/\/doi.org\/10.1016\/j.smim.2012.02.002 (2012).","journal-title":"Semin. Immunol."},{"key":"77466_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov."},{"key":"77466_CR42","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaci.2018.07.014","volume":"142","author":"C Schmidl","year":"2018","unstructured":"Schmidl, C., Delacher, M., Huehn, J. & Feuerer, M. Epigenetic mechanisms regulating T-cell responses.  J. Allergy Clin. Immunol. 142, 728\u2013743, https:\/\/doi.org\/10.1016\/j.jaci.2018.07.014 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"77466_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev-immunol-092719-082622","volume":"38","author":"MJ Shapiro","year":"2020","unstructured":"Shapiro, M. J. & Shapiro, V. S. Chromatin-modifying enzymes in T cell development. Annu. Rev. Immunol. 38, 397\u2013419 https:\/\/doi.org\/10.1146\/annurev-immunol-092719-082622 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"77466_CR44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343\u2013349 https:\/\/doi.org\/10.1038\/nature09784 (2011).","journal-title":"Nature"},{"key":"77466_CR45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.molcel.2014.12.020","volume":"57","author":"S Sanulli","year":"2015","unstructured":"Sanulli, S. et al. Jarid2 methylation via the PRC2 complex regulates H3K27me3 deposition during cell differentiation. Mol. Cell 57, 769\u2013783 https:\/\/doi.org\/10.1016\/j.molcel.2014.12.020 (2015).","journal-title":"Mol. Cell"},{"key":"77466_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","volume":"121","author":"I Su","year":"2005","unstructured":"Su, I. et al. Polycomb group protein EZH2 controls actin polymerization and cell signaling. Cell 121, 425\u2013436 https:\/\/doi.org\/10.1016\/j.cell.2005.02.029 (2005).","journal-title":"Cell"},{"key":"77466_CR47","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1074\/jbc.M115.679332","volume":"291","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Transcriptional regulation of JARID1B\/KDM5B histone demethylase by ikaros, histone deacetylase 1 (HDAC1), and casein kinase 2 (CK2) in B-cell acute lymphoblastic leukemia.  J. Biol. Chem. 291, 4004\u20134018 https:\/\/doi.org\/10.1074\/jbc.M115.679332 (2016).","journal-title":"J. Biol. Chem."},{"key":"77466_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2017.09.001","volume":"171","author":"T Isoda","year":"2017","unstructured":"Isoda, T. et al. Non-coding transcription instructs chromatin folding and compartmentalization to dictate enhancer-promoter communication and T cell fate. Cell 171, 103\u2013119.e18 https:\/\/doi.org\/10.1016\/j.cell.2017.09.001 (2017).","journal-title":"Cell"},{"key":"77466_CR49","doi-asserted-by":"publisher","unstructured":"Assump\u00e7\u00e3o, A. L. F. V. et al. A lineage-specific requirement for YY1 Polycomb Group protein function in early T cell development. Development 148; https:\/\/doi.org\/10.1242\/dev.197319 (2021).","DOI":"10.1242\/dev.197319"},{"key":"77466_CR50","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.1900959","volume":"205","author":"A Astori","year":"2020","unstructured":"Astori, A. et al. ARID1a associates with lymphoid-restricted transcription factors and has an essential role in T cell development. J. Immunol. 205, 1419\u20131432 https:\/\/doi.org\/10.4049\/jimmunol.1900959 (2020).","journal-title":"J. Immunol."},{"key":"77466_CR51","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.4049\/jimmunol.1801684","volume":"202","author":"T Zikmund","year":"2019","unstructured":"Zikmund, T. et al. ISWI ATPase Smarca5 regulates differentiation of thymocytes undergoing \u03b2-selection. J. Immunol. 202, 3434\u20133446 https:\/\/doi.org\/10.4049\/jimmunol.1801684 (2019).","journal-title":"J. Immunol."},{"key":"77466_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116133","volume":"44","author":"BM Allyn","year":"2025","unstructured":"Allyn, B. M. et al. Promoter- and enhancer-dependent cohesin loading initiates chromosome looping to fold Tcrb loci for long-range recombination. Cell Rep. 44, 116133 https:\/\/doi.org\/10.1016\/j.celrep.2025.116133 (2025).","journal-title":"Cell Rep."},{"key":"77466_CR53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41589-022-01248-4","volume":"19","author":"A Kaneshige","year":"2023","unstructured":"Kaneshige, A. et al. A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo. Nat. Chem. Biol. 19, 703\u2013711 https:\/\/doi.org\/10.1038\/s41589-022-01248-4 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"77466_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1182\/blood.2023021985","volume":"144","author":"IM Mayer","year":"2024","unstructured":"Mayer, I. M. et al. Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood 144, 156\u2013170 https:\/\/doi.org\/10.1182\/blood.2023021985 (2024).","journal-title":"Blood"},{"key":"77466_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101602","volume":"23","author":"G Heller","year":"2020","unstructured":"Heller, G. et al. The effect of CDK6 expression on DNA methylation and DNMT3B regulation. iScience 23, 101602 https:\/\/doi.org\/10.1016\/j.isci.2020.101602 (2020).","journal-title":"iScience"},{"key":"77466_CR56","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood.2022018494","volume":"141","author":"T Brandstoetter","year":"2023","unstructured":"Brandstoetter, T. et al. SBNO2 is a critical mediator of STAT3-driven hematological malignancies. Blood 141, 1831\u20131845 https:\/\/doi.org\/10.1182\/blood.2022018494 (2023).","journal-title":"Blood"},{"key":"77466_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu, Y., Dong, Z. & Liu, K. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. J. Exp. Clin. Cancer Res. 43, 23 https:\/\/doi.org\/10.1186\/s13046-024-02949-5 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"77466_CR58","doi-asserted-by":"publisher","unstructured":"Maurer, B., Kollmann, S., Pickem, J., Hoelbl-Kovacic, A. & Sexl, V. STAT5A and STAT5B-twins with different personalities in hematopoiesis and leukemia. Cancers 11; https:\/\/doi.org\/10.3390\/cancers11111726 (2019).","DOI":"10.3390\/cancers11111726"},{"key":"77466_CR59","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity. Nature; https:\/\/doi.org\/10.1038\/s41586-025-09000-3 (2025).","DOI":"10.1038\/s41586-025-09000-3"},{"key":"77466_CR60","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/leu.2009.161","volume":"23","author":"S Eckerle","year":"2009","unstructured":"Eckerle, S. et al. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia 23, 2129\u20132138 https:\/\/doi.org\/10.1038\/leu.2009.161 (2009).","journal-title":"Leukemia"},{"key":"77466_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25379-9","volume":"12","author":"H-C Liang","year":"2021","unstructured":"Liang, H.-C. et al. Super-enhancer-based identification of a BATF3\/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma. Nat. Commun. 12, 5577 https:\/\/doi.org\/10.1038\/s41467-021-25379-9 (2021).","journal-title":"Nat. Commun."},{"key":"77466_CR62","doi-asserted-by":"publisher","unstructured":"Della Chiara, V., Daxinger, L. & Staal, F. J. T. The route of early T cell development: crosstalk between epigenetic and transcription factors. Cells 10; https:\/\/doi.org\/10.3390\/cells10051074 (2021).","DOI":"10.3390\/cells10051074"},{"key":"77466_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","volume":"8","author":"A Zhao","year":"2023","unstructured":"Zhao, A., Zhou, H., Yang, J., Li, M. & Niu, T. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduct. Target. Ther. 8, 71 https:\/\/doi.org\/10.1038\/s41392-023-01342-6 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"77466_CR64","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290.CD-17-0912","volume":"8","author":"F Bellutti","year":"2018","unstructured":"Bellutti, F. et al. CDK6 antagonizes p53-induced responses during tumorigenesis. Cancer Discov. 8, 884\u2013897 https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0912 (2018).","journal-title":"Cancer Discov."},{"key":"77466_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41419-025-07434-1","volume":"16","author":"L Scheiblecker","year":"2025","unstructured":"Scheiblecker, L. et al. CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia. Cell Death Dis. 16, 107 https:\/\/doi.org\/10.1038\/s41419-025-07434-1 (2025).","journal-title":"Cell Death Dis."},{"key":"77466_CR66","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","volume":"30","author":"C Callens","year":"2012","unstructured":"Callens, C. et al. Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 30, 1966\u20131973 https:\/\/doi.org\/10.1200\/JCO.2011.39.7661 (2012).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77466_CR67","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1182\/blood-2012-04-425488","volume":"120","author":"S Le Noir","year":"2012","unstructured":"Le Noir, S. et al. Extensive molecular mapping of TCR\u03b1\/\u03b4- and TCR\u03b2-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL. Blood 120, 3298\u20133309 https:\/\/doi.org\/10.1182\/blood-2012-04-425488 (2012).","journal-title":"Blood"},{"key":"77466_CR68","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/978-1-4419-0296-2_15","volume":"650","author":"S Dadi","year":"2009","unstructured":"Dadi, S., Le Noir, S., Asnafi, V., Beldjord, K. & Macintyre, E. A. Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies. Adv. Exp. Med. Biol. 650, 180\u2013194 https:\/\/doi.org\/10.1007\/978-1-4419-0296-2_15 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"77466_CR69","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1073\/pnas.94.14.7239","volume":"94","author":"GB Udy","year":"1997","unstructured":"Udy, G. B. et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94, 7239\u20137244 https:\/\/doi.org\/10.1073\/pnas.94.14.7239 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77466_CR70","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0023677213516312","volume":"48","author":"M M\u00e4hler Convenor","year":"2014","unstructured":"M\u00e4hler Convenor, M. et al. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab. Anim. 48, 178\u2013192 https:\/\/doi.org\/10.1177\/0023677213516312 (2014).","journal-title":"Lab. Anim."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77466-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77466-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77466-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:09:18Z","timestamp":1792123758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77466-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77466"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77466-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10853"}}